Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
0.124
-0.006 (-4.90%)
Oct 3, 2024, 1:28 PM EDT - Market open

TNXP Stock Forecast

TNXP's stock price has decreased by -99.3% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for TNXP stock have an average target of 53.5, with a low estimate of 11 and a high estimate of 96. The average target predicts an increase of 43,010.39% from the current stock price of 0.12.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $11 $53.5 $96 $96
Change +8763.8% +43010.4% +77257.0% +77257.0%
* Price targets were last updated on Jul 22, 2024.

Analyst Ratings

The average analyst rating for TNXP stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Apr '24May '24Jun '24Jul '24Aug '24Sep '24
Strong Buy 222222
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Alliance Global Partners
Alliance Global Partners
Strong Buy
Maintains
$6$11
Strong Buy Maintains $6$11 +8,763.82% Jul 22, 2024
Dawson James
Dawson James
Strong Buy
Initiates
$96
Strong Buy Initiates $96 +77,256.97% Feb 28, 2024
Alliance Global Partners
Alliance Global Partners
Strong Buy
Maintains
$576$256
Strong Buy Maintains $576$256 +206,185.25% Aug 1, 2023
Alliance Global Partners
Alliance Global Partners
Strong Buy
Maintains
$208$576
Strong Buy Maintains $208$576 +464,041.82% Jun 2, 2023
Alliance Global Partners
Alliance Global Partners
Strong Buy
Reiterates
$1,300
Strong Buy Reiterates $1,300 +1,047,313.38% Jan 12, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
12.63M
from 7.77M
Increased by 62.53%
Revenue Next Year
15.93M
from 12.63M
Increased by 26.17%
EPS This Year
-15.51
from -219.09
EPS Next Year
-11.04
from -15.51
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
----7.77M12.63M15.93M41.71M
Revenue Growth
-----62.53%26.17%161.84%
EPS
--3,530.04-1,620.86-640.26-219.09-15.51-11.04-1.28
EPS Growth
--------
Forward PE
--------
No. Analysts -----554
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 16.6M 21.2M 53.7M
Avg 12.6M 15.9M 41.7M
Low 9.1M 9.3M 30.0M

Revenue Growth

Revenue Growth 202420252026
High
113.6%
67.6%
237.4%
Avg
62.5%
26.2%
161.8%
Low
17.3%
-26.3%
88.3%

EPS Forecast

EPS 202420252026
High -4.61 -1.81 -1.21
Avg -15.51 -11.04 -1.28
Low -34.81 -27.28 -1.32

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.